XIIDRA gtt opht 50 mg/ml 60 monodos 0.2 ml

7680668500024 CH-66850 S01XA25 11.99.0.
XIIDRA gtt opht 50 mg/ml 60 monodos 0.2 ml
google

Details

Product number
6685001
CPT
-
Packaging group
60 x 0.2
Unit
ml
Composition
lifitegrastum 50 mg, natrii chloridum, dinatrii phosphas corresp. phosphas 2.37 mg, natrii thiosulfas, natrii hydroxidum, acidum hydrochloridum dilutum, aqua ad iniectabile, ad solutionem pro 1 ml.

Articles (1)

Xiidra, Augentropfen
Augentropfen
60 x 0.2
View

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
(N/A)
50.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
2.37 MG Substance HBESI
(N/A)
- Substance ANTOX
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Authorization holder

Bausch & Lomb Swiss AG

6301 Zug

Authorization information

Swissmedic authorization number
66850
Drug name
Xiidra, Augentropfen Lösung
Galenic form
AUGT
ATC Code
S01XA25
Authorization status
Z
Dispensation category
B
First authorization
19/12/2018
Authorization expiration date
31/12/9999
IT number
11.99.0.
Domain
Human medicine
Field of application
Syndrom des trockenen Auges

Packaging details

Description (FR)
XIIDRA gtt opht 50 mg/ml 60 monodos 0.2 ml
Description (DE)
XIIDRA Gtt Opht 50 mg/ml 60 Monodos 0.2 ml
Market launch
19/12/2018
Narcotic (BTM)
No

Other packaging sizes